Highly Efficient T2 Cobalt Ferrite Nanoparticles Vectorized for Internalization in Cancer Cells.

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Cobalt ferrite nanoparticles offer unique magnetic properties.
• Targeted drug delivery and imaging require biocompatible nanomaterials.
• Folic acid (FA) receptors are overexpressed in certain cancer cells, making them a target for therapy and imaging.

Purpose of the Study:

• To synthesize uniform cobalt ferrite nanoparticles using an electrochemical method.
• To develop a biocompatible nanoparticle-folic acid (NP-FA) conjugate for targeted cancer cell delivery.
• To evaluate the magnetic and relaxometric properties of NP-FA for potential use as a magnetic resonance imaging (MRI) contrast agent.

Main Methods:

• Electrochemical synthesis of cobalt ferrite nanoparticles in aqueous media.
• Characterization of colloidal, magnetic, and relaxometric properties.
• Development and in vitro assessment of NP-FA conjugate biocompatibility and targeting in HeLa cancer cells.
• MTT assay and cytoskeleton morphological analysis for biocompatibility.
• Transverse relaxivity (r2) measurements and T2 contrast evaluation.

Main Results:

• Uniform cobalt ferrite nanoparticles were successfully synthesized with reproducible iron and cobalt ratios.
• A stable and biocompatible NP-FA conjugate was developed, demonstrating effective targeting of FA receptor-positive HeLa cells.
• High transverse relaxivity (r2) of 479 Fe+Co mM−1s−1 was achieved in colloidal suspension.
• In vitro studies in HeLa cells showed a significant negative T2 contrast effect.

Conclusions:

• The synthesized NP-FA conjugate is a promising biomaterial for biomedical applications.
• NP-FA exhibits excellent targeting capabilities for cancer cells overexpressing FA receptors.
• The observed magnetic properties suggest NP-FA's potential as an effective MRI contrast agent for cancer diagnosis.